Fractionated <sup>90</sup>Y-Ibritumomab Tiuxetan Radioimmunotherapy As an Initial Therapy of Follicular Lymphoma: An International Phase II Study in Patients Requiring Treatment According to GELF/BNLI Criteria - Concepedia

Concepedia

Publication | Open Access

Fractionated <sup>90</sup>Y-Ibritumomab Tiuxetan Radioimmunotherapy As an Initial Therapy of Follicular Lymphoma: An International Phase II Study in Patients Requiring Treatment According to GELF/BNLI Criteria

DOI Full Paper Access

60

Citations

26

References

2013

Year

Tim Illidge, Sam Mayes, Ruth Pettengell, Andrew Bates, Mike Bayne, John Radford, W. David J. Ryder, Steven Le Gouill, Fabrice Jardin, Jill Tipping,

Journal of Clinical Oncology

Abstract

Fractionated RIT using (90)Y-IT is an effective initial treatment for advanced-stage FL in patients with higher tumor burden requiring treatment.

References

	Year	Citations

Page 1